Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Growth Hormone Deficiency
Dose: Subcutaneous Injection – Not to exceed 0.004 mg/kg/day
Frequency: once daily
Duration: initially for 6 weeks
Note: may increase up to 0.016 mg/kg/day maximum
Indication: Growth Hormone Deficiency
Condition: Nonweight-based dosing
Dose: Subcutaneous Injection – 0.2 mg/day (0.15-0.3 mg/day range)
Frequency: once daily
Note: initially; may increase every 1-2 months by 0.1-0.2 mg/day based on clinical response and/or serum IGF-I levels

Child Dose

Clinical InformationAdministration Information
Indication: Growth Hormone Deficiency
Dose: Subcutaneous Injection – 0.024-0.034 mg/kg/day
Frequency: 6-7 days/week
Indication: Small for Gestational Age
Dose: Subcutaneous Injection – Not to exceed 0.067 mg/kg/day
Note: Not to exceed 0.067 mg/kg/day
Administration
  • Subcutaneous injection
  • Rotate injection sites
Side Effect

Drug Interaction

Drug NameRisk Factors
Corticosteroids (Prednisone, Prednisolone, Methylprednisolone, Dexamethasone, Hydrocortisone)
High doses may inhibit growth-promoting effects of somatropin

Disease Interaction

Disease NameRisk Factors
Acute Critical Illness
Can worsen patient condition
Active Neoplasms
May stimulate tumor growth

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store at 2-8° C.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.